Key result
Reverse cholesterol transport modulation boosts HDL and shows anti-atherosclerotic potential while maintaining cholesterol homeostasis.
Answers are grounded in this paper and cite their sources.
Shows that reverse cholesterol transport via high-density lipoproteins maintains cholesterol homeostasis, indicating therapeutic potential for elevating HDL in atherosclerosis.
New research firmly establishes the reverse cholesterol transport pathway, which carries cholesterol through the high-density lipoprotein, as significant in normal cholesterol homeostasis. Modulation of this pathway by transgenic and pharmacological techniques indicates potential therapeutic functions for increased high-density lipoprotein levels in atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Christopher J. Fielding (1991) studied this question. Reverse cholesterol transport modulation increases high-density lipoprotein levels and demonstrates potential therapeutic utility in atherosclerosis while maintaining normal cholesterol homeostasis.
Synapse has enriched 10 related papers. Consider them for comparative context: